Rami Abusaleh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Rami Abusaleh has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Ali Kanaan
School of Medicine, University of Jordan, Amman, Jordan
1 shared publication - Asmaa S. AbuMaziad
Department of Pediatrics, College of Medicine Tucson, The University of Arizona, Tucson, AZ 85724, USA
1 shared publication - Barham K. Abu Dayyeh
Mayo Clinic, Rochester, USA
1 shared publication Daniel B. Maselli
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
1 shared publicationFadi Al Hadidi
Division of Orthopedic Surgery & Spine Unit, Special Surgery Department, University of Jordan, Amman, Jordan
1 shared publication- Fatima Alnaimat
Department of Internal Medicine, Division of Rheumatology, School of Medicine, The University of Jordan, Amman, Jordan
1 shared publication
Latest Publications
- 16 June 2022
- Published by Elsevier in Gastroenterology
- Vol. 162 (7)
Mo1168: TRENDS OF ESOPHAGEAL ADENOCARCINOMA INCIDENCE IN THE UNITED STATES: IS THERE A DEMOGRAPHIC SHIFT?
- 16 June 2022
- Published by Elsevier in Gastroenterology
- Vol. 162 (7)
Mo1168: TRENDS OF ESOPHAGEAL ADENOCARCINOMA INCIDENCE IN THE UNITED STATES: IS THERE A DEMOGRAPHIC SHIFT?
- 1 December 2021
- Published by Springer Nature in Journal of Perinatology
- Vol. 41 (12) , 2704-2712
Congenital nephrotic syndrome
Congenital nephrotic syndrome (CNS), a challenging form of nephrotic syndrome, is characterized by massive proteinuria, hypoalbuminemia, and edema. Extensive leakage of plasma proteins is the main feature of CNS. Patients can be diagnosed in utero or during the first few weeks of life, usually before three months. The etiology of CNS can be related to either genetic or nongenetic etiologies. Pathogenic variants in NPHS1, NPHS2, LAMB2, WT1, and PLCE1 genes have been implicated in this disease. The clinical course is complicated by significant edema, infections, thrombosis, hypothyroidism, failure to thrive, and others. Obtaining vascular access, frequent intravenous albumin infusions, diuretic use, infection prevention, and nutritional support are the mainstay management during their first month of life. The best therapy for these patients is kidney transplantation. CNS diagnosis and treatment continue to be a challenge for clinicians. This review increases the awareness about the pathogenesis, diagnosis, and management of CNS patients.
- 1 December 2021
- Published by Springer Nature in Journal of Perinatology
- Vol. 41 (12) , 2704-2712
Congenital nephrotic syndrome
Congenital nephrotic syndrome (CNS), a challenging form of nephrotic syndrome, is characterized by massive proteinuria, hypoalbuminemia, and edema. Extensive leakage of plasma proteins is the main feature of CNS. Patients can be diagnosed in utero or during the first few weeks of life, usually before three months. The etiology of CNS can be related to either genetic or nongenetic etiologies. Pathogenic variants in NPHS1, NPHS2, LAMB2, WT1, and PLCE1 genes have been implicated in this disease. The clinical course is complicated by significant edema, infections, thrombosis, hypothyroidism, failure to thrive, and others. Obtaining vascular access, frequent intravenous albumin infusions, diuretic use, infection prevention, and nutritional support are the mainstay management during their first month of life. The best therapy for these patients is kidney transplantation. CNS diagnosis and treatment continue to be a challenge for clinicians. This review increases the awareness about the pathogenesis, diagnosis, and management of CNS patients.
- 12 May 2021
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 54 (05) , E203-E204
Feasibility of a single endoscopic plication procedure for the treatment of gastroesophageal reflux disease and obesity
Gastroesophageal reflux disease (GERD) and obesity are common disorders in the developed world, often coinciding in the same patients [1]. Obesity exacerbates GERD and reduces the efficacy of anti-reflux surgery [2]. This creates management challenges for overlapping GERD and obesity, which compels the development of safe, effective, and durable therapies for patients with these conditions. The Incisionless Operating Platform (USGI Medical, San Clemente, California, USA) is a handheld endoscopic tool that acquires full-thickness gastric or gastroesophageal tissue using 3.3-cm jaws. The tissue is then pierced with a catheter needle to allow for the deployment of paired suture anchors, thereby creating a 6.6-cm full-thickness plication ([Video 1]). The Incisionless Operating Platform may be operated in both the forward-facing and retroflexed orientation. This unique feature permits the endoscopic creation of plications that both facilitate weight loss (such as those used in the Primary Obesity Surgery Endoluminal gastric remodeling procedure), as well as plications at the gastroesophageal junction that may serve as a barrier against pathologic reflux (such as those used in transoral incisionless fundoplication) [3] [4]. The Incisionless Operating Platform consequently provides the theoretical opportunity to co-treat obesity and GERD in the same patient during a single procedure ([Fig. 1]). In this video, we describe the use of the platform to create gastric plications in the pattern of the Primary Obesity Surgery Endoluminal 2 procedure, which tubularizes the stomach along the greater curvature and shortens its aperture to facilitate weight loss in adults with obesity. We then describe the use of the Incisionless Operating Platform to create gastric and gastroesophageal plications to serve as a barrier against gastroesophageal reflux in a large canine model. We conclude with the combination plication procedure in an ex-vivo porcine stomach, providing the conceptual framework for examining the combination procedure in humans. Video 1 Single endoscopic plication procedure for treatment of gastroesophageal reflux disease and obesity. Source for graphical illustration: Mayo Clinic. Source for IOP: USGI Medical. Endoscopy_UCTN_Code_TTT_1AO_2AJ Publication Date: 12 May 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 12 May 2021
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 54 (05) , E203-E204
Feasibility of a single endoscopic plication procedure for the treatment of gastroesophageal reflux disease and obesity
Gastroesophageal reflux disease (GERD) and obesity are common disorders in the developed world, often coinciding in the same patients [1]. Obesity exacerbates GERD and reduces the efficacy of anti-reflux surgery [2]. This creates management challenges for overlapping GERD and obesity, which compels the development of safe, effective, and durable therapies for patients with these conditions. The Incisionless Operating Platform (USGI Medical, San Clemente, California, USA) is a handheld endoscopic tool that acquires full-thickness gastric or gastroesophageal tissue using 3.3-cm jaws. The tissue is then pierced with a catheter needle to allow for the deployment of paired suture anchors, thereby creating a 6.6-cm full-thickness plication ([Video 1]). The Incisionless Operating Platform may be operated in both the forward-facing and retroflexed orientation. This unique feature permits the endoscopic creation of plications that both facilitate weight loss (such as those used in the Primary Obesity Surgery Endoluminal gastric remodeling procedure), as well as plications at the gastroesophageal junction that may serve as a barrier against pathologic reflux (such as those used in transoral incisionless fundoplication) [3] [4]. The Incisionless Operating Platform consequently provides the theoretical opportunity to co-treat obesity and GERD in the same patient during a single procedure ([Fig. 1]). In this video, we describe the use of the platform to create gastric plications in the pattern of the Primary Obesity Surgery Endoluminal 2 procedure, which tubularizes the stomach along the greater curvature and shortens its aperture to facilitate weight loss in adults with obesity. We then describe the use of the Incisionless Operating Platform to create gastric and gastroesophageal plications to serve as a barrier against gastroesophageal reflux in a large canine model. We conclude with the combination plication procedure in an ex-vivo porcine stomach, providing the conceptual framework for examining the combination procedure in humans. Video 1 Single endoscopic plication procedure for treatment of gastroesophageal reflux disease and obesity. Source for graphical illustration: Mayo Clinic. Source for IOP: USGI Medical. Endoscopy_UCTN_Code_TTT_1AO_2AJ Publication Date: 12 May 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Open Access
- 1 November 2020
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 13, 2971-2978
The Efficacy of Therapeutic Selective Nerve Block in Treating Lumbar Radiculopathy and Avoiding Surgery
Background: Selective nerve root block (SNRB) is a procedure that can be used as a diagnostic or a therapeutic method. SNRB can be used in multiple sites, including cervical and lumbar . Our study aims to investigate the clinical effectiveness of the use of fluoroscopically guided therapeutic selective nerve root block as a non-surgical symptom management of lumbar radiculopathy. Patients and Methods: This is a prospective study of therapeutic nerve root block in 76 patients with low back pain and/or sciatica at Jordan University Hospital. Data was collected by independent clinical interviewers, and visual analogue score (VAS) was used to measure pain severity. Results: A total of 76 patients, 25 (32.8%) males and 51 (67.2%) females, underwent SNRB. 69 (90.7%) patients improved immediately after the procedure. Out of the total, 22 (28.9%) patients showed a long-term relief of symptoms and did not experience any recurrence during the three months of follow-up, while 47 (61.8%) experienced a recurrence of pain. In patients experiencing recurrence of symptoms, 35 needed surgery. Conclusion: Therapeutic SNRB is an important procedure in the pain management of patients with lumbar radiculopathy caused by lumbar disc prolapse and foraminal stenosis. Our study showed that avoidance of surgery was achieved in up to 54% of patients; pain relief for at least 6 months was achieved in up to 29% of patients after a single SNRB. This makes it a very good second line of management after conservative treatment and a possible method to delay, and sometimes cease, the need for surgery.
- 1 November 2020
- Published by Taylor & Francis in Journal of Pain Research
- Vol. ume 13, 2971-2978
Open AccessThe Efficacy of Therapeutic Selective Nerve Block in Treating Lumbar Radiculopathy and Avoiding Surgery
Background: Selective nerve root block (SNRB) is a procedure that can be used as a diagnostic or a therapeutic method. SNRB can be used in multiple sites, including cervical and lumbar . Our study aims to investigate the clinical effectiveness of the use of fluoroscopically guided therapeutic selective nerve root block as a non-surgical symptom management of lumbar radiculopathy. Patients and Methods: This is a prospective study of therapeutic nerve root block in 76 patients with low back pain and/or sciatica at Jordan University Hospital. Data was collected by independent clinical interviewers, and visual analogue score (VAS) was used to measure pain severity. Results: A total of 76 patients, 25 (32.8%) males and 51 (67.2%) females, underwent SNRB. 69 (90.7%) patients improved immediately after the procedure. Out of the total, 22 (28.9%) patients showed a long-term relief of symptoms and did not experience any recurrence during the three months of follow-up, while 47 (61.8%) experienced a recurrence of pain. In patients experiencing recurrence of symptoms, 35 needed surgery. Conclusion: Therapeutic SNRB is an important procedure in the pain management of patients with lumbar radiculopathy caused by lumbar disc prolapse and foraminal stenosis. Our study showed that avoidance of surgery was achieved in up to 54% of patients; pain relief for at least 6 months was achieved in up to 29% of patients after a single SNRB. This makes it a very good second line of management after conservative treatment and a possible method to delay, and sometimes cease, the need for surgery.